Isotretinoin (Absorica Ld, Clarus) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 13, 2026
Also sold as: Absorica Ld, Clarus, Accutane Roche
Some Isotretinoin products are in shortage in Canada (2 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 1, 2026.
A retinoid used to treat severe acne.
Products affected
2 / 8
In shortage since
Jun 5, 2026
Est. full return
Sep 1, 2026
Reports on file
36
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
CLARUS
40MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257963 · since Jun 19, 2026, est. end Sep 1, 2026 · Demand increase for the drug.
Active shortage
CLARUS
10MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257955 · since Jun 5, 2026, est. end Sep 1, 2026 · Demand increase for the drug.
Resolved
CLARUS
40MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257963 · ended Mar 17, 2026 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
8MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539047 · ended Sep 5, 2025 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
16MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539055 · ended Sep 5, 2025 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
16MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539055 · ended Jul 10, 2025 · Delay in shipping of the drug.
Resolved
ACCUTANE ROCHE
40MG · CAPSULE · HOFFMANN-LA ROCHE LIMITED
DIN 00582352 · ended Apr 1, 2025 · Disruption of the manufacture of the drug.
Resolved
ACCUTANE ROCHE
10MG · CAPSULE · HOFFMANN-LA ROCHE LIMITED
DIN 00582344 · ended Apr 1, 2025 · Disruption of the manufacture of the drug.
Resolved
CLARUS
10MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257955 · ended Mar 25, 2025 · Disruption of the manufacture of the drug.
Resolved
CLARUS
40MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257963 · ended Mar 13, 2025 · Disruption of the manufacture of the drug.
Resolved
ABSORICA LD
16MG · CAPSULE · SUN PHARMACEUTICAL INDUSTRIES LIMITED
DIN 02539055 · ended Mar 5, 2025 · Delay in shipping of the drug.
Resolved
CLARUS
10MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02257955 · ended Jan 6, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 36 reports. All reports are on file with Health Canada.
What's happening
Isotretinoin is currently affected by 2 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Isotretinoin is classified under “ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE” (ATC D10BA).
Recent changes
Jul 13, 2026
Estimated end date pushed back : Aug 18, 2026 → Sep 1, 2026
Jul 13, 2026
Estimated end date pushed back : Aug 18, 2026 → Sep 1, 2026
Common questions
What is Isotretinoin used for?
A retinoid used to treat severe acne.
When will Isotretinoin be back in stock in Canada?
The latest manufacturer estimate is Sep 1, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Isotretinoin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.